Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert F. Apple currently holds 2,526,055 shares of ANTARES PHARMA, INC. (ATRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert F. Apple has been a net seller of ATRS stock. They have purchased $43.2K and sold $5.8M worth of shares.
Robert F. Apple's most recent insider trade was on May 24, 2022, when they sold 374,099 shares at $5.60 per share.
Robert F. Apple serves as Executive at ANTARES PHARMA, INC. (ATRS). They have executed 121 insider transactions totaling $5.8M over their tenure at the company.
Robert F. Apple holds the position of Executive at ANTARES PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Robert F. Apple has shown a selling trading pattern, with $43.2K in total purchases and $5.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert F. Apple was on May 24, 2022, when they sold $10.5M worth of ATRS shares. This transaction involved 1,876,693 shares at $5.60 per share.
Robert F. Apple currently owns 2,526,055 shares of ANTARES PHARMA, INC. (ATRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert F. Apple's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert F. Apple has 121 Form 4 filings on record as an insider at ANTARES PHARMA, INC..
Set alerts for Robert F. Apple and 40,000+ other insiders.